NovaBay Pharmaceuticals I...

AMEX: NBY · Real-Time Price · USD
0.55
-0.05 (-9.06%)
At close: Aug 15, 2025, 3:30 PM
0.62
13.30%
After-hours: Aug 15, 2025, 03:58 PM EDT

NovaBay Pharmaceuticals Income Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year Q1 2025 Q4 2024 Q3 2024 Q2 2024 Q1 2024 Q4 2023 Q3 2023 Q2 2023 Q1 2023 Q4 2022 Q3 2022 Q2 2022 Q1 2022 Q4 2021 Q3 2021 Q2 2021 Q1 2021
Period Ending Mar 31, 2025 Dec 31, 2024 Sep 30, 2024 Jun 30, 2024 Mar 31, 2024 Dec 31, 2023 Sep 30, 2023 Jun 30, 2023 Mar 31, 2023 Dec 31, 2022 Sep 30, 2022 Jun 30, 2022 Mar 31, 2022 Dec 31, 2021 Sep 30, 2021 Jun 30, 2021 Mar 31, 2021
Revenue
7.15M 9.78M 11.2M 12.01M 14.22M 14.72M 14.63M 15.2M 13.64M 13.14M 12.14M 10.15M 9.24M 8.42M 7.67M 8M 9.85M
Cost of Revenue
2.46M 3.3M 4.41M 4.97M 6.47M 6.82M 6.8M 6.83M 6.02M 5.95M 5.27M 4.32M 3.43M 2.78M 2.38M 2.42M 3.84M
Gross Profit
4.69M 6.48M 6.79M 7.04M 7.75M 7.89M 7.83M 8.37M 7.62M 7.2M 6.87M 5.84M 5.81M 5.64M 5.29M 5.58M 6M
Operating Income
-6.69M -4.97M -4.48M -4.54M -4.84M -5M -1.48M -816K -1.61M -2.26M -8.19M -10.02M -9.72M -8.86M -7.43M -7.2M -6.41M
Interest Income
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Pretax Income
-8.46M -8.21M -11M -10.54M -10.99M -9.64M -13.74M -12.12M -12.24M -10.61M -2.56M -4.71M -4.42M -5.82M -7.42M -8.35M -10.97M
Net Income
3.66M -7.22M -10.12M -10.66M -13.11M -11.64M -15.73M -19.77M -17.89M -16.27M -8.95M -5.45M -5.15M -6.56M -7.42M -8.35M -10.97M
Selling & General & Admin
10.77M 11.41M 11.24M 11.53M 12.53M 12.83M 14.6M 14.45M 14.47M 14.7M 14.94M 15.77M 15.47M 14.46M 12.65M 12.59M 12.13M
Research & Development
23K 42K 36K 43K 61K 68K 130K 160K 173K 175K 117K 86K 67K 44K 72K 187K 281K
Other Expenses
589K n/a n/a n/a n/a -5K -5K -5K -8K -3K -3K -3K n/a 2K 2K 2K 2K
Operating Expenses
11.38M 11.46M 11.28M 11.58M 12.59M 12.9M 14.73M 14.61M 14.65M 14.88M 15.05M 15.86M 15.53M 14.51M 12.72M 12.78M 12.42M
Interest Expense
471K 904K 871K 733K 934K 506K 506K 506K 8K 3K 3K 3K n/a n/a n/a n/a n/a
Selling & Marketing Expenses
2.98M 4.03M 4.43M 5.2M 5.9M 6.49M 7.01M 7.13M 7.16M 7.21M 7.17M 7.19M 7.23M 7.22M 6.82M 6.66M 6.29M
Cost & Expenses
13.84M 14.76M 15.68M 16.55M 19.06M 19.72M 21.53M 21.44M 20.67M 20.82M 20.33M 20.17M 18.97M 17.28M 15.09M 15.2M 16.26M
Income Tax Expense
n/a 124K 124K 124K -132K -251K -3.74M -4.06M -3.8M -3.81M 417K 737K 734K 734K 3K 4K 5K
Shares Outstanding (Basic)
5.31M 4.88M 3.71M 1.16M 652.91K 88.29K 134.06K 91K 75.17K 54.09K 45.83K 43.06K 40.89K 36.99K 36.67K 34.74K 34.11K
Shares Outstanding (Diluted)
5.42M 4.88M 3.71M 1.16M 704.91K 197.06K 134.06K 91K 58.14K 54.09K 45.83K 43.06K 40.89K 36.99K 36.67K 34.74K 34.11K
EPS (Basic)
-0.87 -7.23 -53.42 -65.93 -105.48 -123.69 -228.88 -342.17 -351.3 -330.88 -203.3 -139.32 -142.78 -184.58 -211.87 -248 -375.19
EPS (Diluted)
-0.89 -7.23 -53.42 -65.93 -105.48 -123.69 -228.88 -342.17 -351.3 -330.88 -203.3 -139.32 -142.78 -184.58 -211.87 -248 -375.19
EBITDA
-6.49M -6.29M -5.85M -5.98M -6.3M -4.55M -6.37M -5.59M -6.27M -7.2M -7.74M -9.68M -9.49M -8.74M -7.38M -7.16M -6.37M
EBIT
-6.98M -6.31M -5.81M -5.86M -5.8M -4.49M -6.38M -5.72M -6.64M -7.68M -8.19M -10.02M -9.72M -8.86M -7.43M -7.2M -6.41M
Depreciation & Amortization
256K 213K 168K 124K 164K 203K 276K 344K 413K 483K 447K 341K 232K 120K 44K 43K 46K